#Japan #Health Management #Osaka #Glucose Flight #Diabetes Society

The PHAGE to Showcase Innovations at the Japan Diabetes Society Annual Meeting

The PHAGE, Inc., headquartered in Shibuya, Tokyo, has announced its participation in the upcoming 69th Annual Meeting of the Japan Diabetes Society, taking place from May 21 to May 23, 2026, at the Osaka International Conference Center and the Hotel RIHGA Royal Osaka. The theme of this year's meeting is "IMAGINE: Aiming Together for Radiant Diabetes Healthcare and Medicine."

Background of Participation

In Japan, it is estimated that around 10 million people suffer from type 2 diabetes. While optimizing HbA1c management is crucial, supporting behavioral changes to regulate post-meal hyperglycemia has emerged as an essential aspect of treatment. However, visualizing patients' dietary habits and encouraging continuous behavioral change within the constraints of outpatient care remains a significant challenge.

The PHAGE has developed the Glucose Flight® platform, which integrates continuous glucose monitoring (CGM) data with dietary records. This platform, facilitated by consultations with dietitians and AI technologies, supports the management of post-meal blood sugar and promotes behavioral change. Through this annual meeting's exhibition and seminar, the company aims to widely disseminate successful implementation examples and scientific evidence to medical institutions.

Luncheon Seminar Details

• - Date: May 23, 2026
• - Time: 12:00 PM - 12:50 PM
• - Location: Event Hall S-9, 3rd Floor, Osaka International Conference Center
• - Seating Capacity: 500 seats

Towards the end of the seminar, a 15-minute panel discussion is planned, enabling attendees to explore how clinical knowledge and the potential of AI and mathematical analysis can be applied in daily medical practice. This discussion aims to provide practical insights for clinicians to apply immediately in their practice.

Exhibition Booth Overview

• - Location: Event Hall S-9, 3rd Floor, Osaka International Conference Center
• - Access: Gran Cube Osaka (Osaka International Conference Center)

At the booth, the PHAGE will present concrete operational images of its platform through real-world use cases from medical institutions. Medical professionals will receive direct insights and information on trial applications and consultation for implementation.

Mini-Seminar Overview

Note: The content, speakers, and times of each session are subject to change. Please stay tuned for updates.

About Glucose Flight®

The Glucose Flight® health management service application integrates with CGM to measure and data-fy the factors affecting post-meal blood glucose variations based on dietary intake and quantity. It also includes a function to automatically generate recommendations for diet and exercise to reduce disease risk.

The PHAGE recognizes that traditional healthcare approaches often lead to uniform guidance for diabetes patients. By utilizing data on post-meal blood glucose fluctuations, the potential for personalized support and treatment tailored to each patient is expanded. Through analyzing blood glucose data, the company aims to apply acquired knowledge to other biological data analyses to prevent the onset and worsening of lifestyle-related diseases, striving for a healthier and wealthier society.

Company Profile

• - Company Name: THE PHAGE, Inc.
• - Representative: Shohei Tokunaga
• - Established: July 15, 2021
• - Location: 2-16-8 Shibuya, Shibuya-ku, Tokyo, VEIL SHIBUYA 2F
• - Business Description: Development and provision of the post-meal blood sugar management platform "Glucose Flight®," deployment of digital health solutions utilizing Japan's first blood sugar model, and collaborative research and R&D support with medical institutions, insurance companies, and government authorities.
• - Website: THE PHAGE

For Media Inquiries

Please contact the Public Relations Department at: [email protected]